Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
8,268,251
-
Share change
-
-1,852,043
-
Total reported value
-
$8,018,000
-
Put/Call ratio
-
24%
-
Price per share
-
$0.97
-
Number of holders
-
47
-
Value change
-
-$1,920,365
-
Number of buys
-
13
-
Number of sells
-
26
Institutional Holders of REPROS THERAPEUTICS INC - COM NEW (RPRX) as of Q1 2016
As of 31 Mar 2016,
REPROS THERAPEUTICS INC - COM NEW (RPRX) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,268,251 shares.
The largest 10 holders included
FMR LLC, Sarissa Capital Management LP, VANGUARD GROUP INC, Gruss Capital Management LP, BlackRock Institutional Trust Company, N.A., MILLENNIUM MANAGEMENT LLC, GENERAL AMERICAN INVESTORS CO INC, Allegis Investment Advisors, LLC, JACOBS LEVY EQUITY MANAGEMENT, INC, and D. E. Shaw & Co., Inc..
This page lists
47
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.